The MCW Cancer Center research efforts are focused around four programs that leverage institutional and partner investments to build on existing scientific expertise. These Research Programs were selected because of strong leadership, current and potential funding and faculty opportunities and suitability for collaboration between projects and investigators.
Discovering biological abnormalities and chemical characteristics of cancer cells -- epigenetics, carcinogenesis, signal transduction, and alternations in functions and regulations -- to develop more effective methods of preventing and treating cancer.
Program Leaders: Balaraman Kalyanaraman, PhD, and Carol Williams, PhD
2. Imaging & Tumor Microenvironment (ITM)
Understanding the interaction of cancer cells with their environment and the progression of cancer. Creating new innovations in early detection, imaging, and targeted screening and treatment of cancer.
Program Leaders: Kathleen Schmainda, PhD and Michael Dwinell, PhD
3. Hematologic Malignancy & Transplantation (HMT)
Understanding how transferring cells from one person to another can kill cancer cells, and discovering new ways to reset the immune system. Improving survivorship and quality of life for cancer patients receiving blood and bone marrow transplants.
Program Leader: William Drobyski, MD
4. Population Sciences (PS)
Focus on underserved populations and cancer disparities, survivorship, and reducing cancer incidence and rates of death across all demographic groups.
Program Leaders: Ann Nattinger, MD, MPH, and Joan Neuner, MD, MPH